Science 2010,327(5964):469–474.PubMedCrossRef 23. Ma XL, Chen FH, Zhou X, Chang WJ, Dai YY: Molecular characteristic of Staphylococcus aureus isolates in a Chinese teaching hospital. African Journal of Microbiology Research 2011,5(19):2969–2974. 24. Coombs GW, Monecke S, Ehricht R, Slickers P, Pearson JC, Tan HL, Christiansen KJ, O’Brien FG: Differentiation of clonal complex 59 community-associated Go6983 methicillin-resistant Staphylococcus aureus in Western Australia. Antimicrob Agents Chemother 2010,54(5):1914–1921.PubMedCrossRef 25. Chen H, Liu Y, Jiang X, Chen M, Wang

H: Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother 2010,54(5):1842–1847.PubMedCrossRef Competing interests We have no any Competing

interests. Our manuscript doesn’t involve any ethical issues. Authors’ find more contributions WZ, XM conceived the study and participated in its design. YD, HL participated in field and clinical aspects of the study. WZ carried out laboratory work. WS, WZ drafted the manuscript. XM, WS, WZ, XZ, WC edited the manuscript. All authors read and approved the final version of the manuscript.”
“Background Yak (Bos grunniens) and cattle (Bos taurus) separated about 4.4 to 5.3 million years ago [1]. While cattle have a worldwide distribution in most of the low lands, the yak has dominated in high lands especially Sirolimus around the Hindu Kush-Himalayan region and the Qinghai-Tibetan Plateau (QTP), ranging from 3,000 to 5,500 m above sea level. The yak is one of the world’s most remarkable domestic animals, and has been second reported as a typical four season grazing ruminant in the QTP [2]. In order to adapt to the harsh environment with severe cold, less oxygen, strong ultra-violet (UV) radiation, and poor forage resources, yaks have evolved special adaptations in physiology, nutrient metabolism and foraging [3–8]. Recently, Shao et al [5] anatomically compared the yak tongue with the cattle tongue, and found that the yak tongue was better adapted to the

harsh characteristics of Tibetan pasture. Other recent studies have shown that yaks have an efficient nitrogen metabolism, suggesting an adaptation mechanism to their low-N dietary ingestion under harsh grasslands conditions of the QTP area [8]. Subsequently, using the sulfur-hexafluoride (SF6) tracer technique, Ding et al [9] measured the enteric methane emissions of yak in the QTP area and showed that yaks produce less methane (per unit of live weight) compared to other ruminants, such as cattle. Greenhouse gases have become a major issue in the world and ruminant livestock are an important source of global enteric methane. Enteric methane gas is produced by microorganisms, called methanogens, in the digestive tract of ruminant livestock during digestion of feed and represents a direct loss of gross energy intake that could more efficiently be used by the animal for increased productivity [10].

3. The

high-resolution transmission electron microscopy (HRTEM) images were obtained using JEOL-2010 (Akishima-shi, Japan).   4. The UV–vis absorption spectra of the samples were measured using a UV-1800 ultraviolet–visible spectrophotometer (Shanghai Meipuda Instrument Co., Ltd., Shanghai, China).   The samples used for characterization were ultrasonically dispersed in absolute ethanol for 30 min before the TEM and HRTEM tests. Results and discussion Characterization of SiO2 · Eu2O3 HSs Newly prepared silica spheres were used to fabricate HSSs. The monodispersed SiO2 spheres with an average diameter of 230 nm (Figure 1A) were fabricated using the Stöber method [37–39] and acted as the template. The hollow SiO2 · Eu2O3 HSs were uniform, as shown in the HRTEM image in Figure 1B, whose size Entospletinib solubility dmso was nearly unchanged. XRD curves in Figure 1C demonstrate that both the SiO2 sphere and SiO2 · Eu2O3 hollow sphere are amorphous (compared with ICSD #174). The absence of diffraction peaks for Eu2O3 was owing to the few content of Eu2O3 in the sample. Figure 2 shows the HRTEM image and energy-dispersive spectrometer (EDS) analysis of SiO2 · Eu2O3 HSs. A large number of holes with different sizes on the surface of SiO2 · Eu2O3 YH25448 mouse HSs could be observed in Figure 2A, which belonged to a range of mesoporous structures according to the diameter of holes. The SiO2 · Eu2O3

HSs with numerous mesoporous structures indicated that they are potential drug carriers for application in Cyclooxygenase (COX) medicine, e.g., targeting therapy. The results of the EDS analysis showed that the content of O, Si, and Eu was 72.43%, 25.15%, and 2.22%, respectively. The microcontent of Ge (0.19%) was due to the impurity coming from the reagent of Eu2O3. The SiO2 HSs were amorphous according to their XRD pattern, so the lattice fringe that appeared on the HRTEM image (Figure 2B) stemmed from Eu2O3. The measured interplanar MK-4827 nmr spacing of 0.3 nm corresponded to the (001) plane of Eu2O3. Obviously, Eu2O3 is one component of the final product, and it may be embedded into the shells or form a kind of composite similar to ‘alloy’ or a solid solution. Further

research is in progress. Being doped with Eu2O3 on the surface of SiO2 HSs, the obtained samples can emit bright red light under an ultraviolet beam. HRTEM observation also revealed that the HSs produced in the solution contained Re3+ ions that formed a mesoporous structure with different orientations. Figure 1 TEM image of SiO 2 sphere (A), HRTEM image of SiO 2 ∙Eu 2 O 3 HSs (B), XRD patterns of SiO 2 sphere and SiO 2 ∙Eu 2 O 3 HSs (C). The insert is magnification of one segment of XRD. Figure 2 HRTEM images and EDS pattern of SiO 2   · Eu 2 O 3 HSs. (A) Mesoporous structure of SiO2 · Eu2O3. (B) The interplanar spacing of the (001) plane of Eu2O3. (C, D) EDS pattern and results of SiO2 · Eu2O3 HSs, respectively.

For example, blood loss and fluid shifts needing immediate replacement can quickly induce hemodynamic instability, electrolyte disturbance, oxygen supply and demand imbalances that can lead to acute organ dysfunction such as unstable arrhythmias. This process is commonly misinterpreted by non-anaesthesiologists as an evaluation GSK1904529A of fitness

for anaesthesia, assuming the anaesthesia is the most life-threatening process to the patient. On the contrary, when performed carefully with appropriate monitoring and timely interventions, the period of anaesthesia represents a period of relative stability for the patient in the vast majority of time. Rather, preoperative risk assessment evaluates the capacity of the patient to withstand the acute physiological perturbations resulting from the entire operative period that extends well into the recovery phase. The critical element is to estimate learn more whether the patient can meet the increased oxygen demand due to the acute stress response to surgery. Therefore, the assessment tends to focus upon the cardiac and respiratory system as these are critical determinants of oxygen click here supply to tissues. Another point of focus of the examination is conditions affecting the level of consciousness, whether it involves the central nervous system or secondary to metabolic disturbances. Acute delirium

is associated with high perioperative morbidity and mortality. Delayed emergence from anaesthesia may occur in OSBPL9 patients suffering from preoperative delirium. Alternatively, the effects of general anaesthesia may further contribute to the delirious state, complicating the clinical picture. Pulmonary risk stratification Risk factors for developing postoperative pulmonary complications In a systematic review of more than 100 studies, the authors identified

patient, procedure and laboratory related risk factors for the development of postoperative pulmonary complications in non-cardiothoracic surgery that were supported by good evidence. Those of interest to the fracture hip population include advanced age, American Society of Anesthesiologists class 2 or higher, functional dependence, chronic obstructive pulmonary disease and congestive heart failure, emergency surgery, general anaesthesia, prolonged surgery and serum albumin level less than 30 g/L. Interestingly, for the study population there was insufficient evidence to support preoperative spirometry as a tool to stratify risk [4]. Similar risk factors have also been incorporated into a respiratory failure risk index [5].The presence of any of these conditions should alert the primary treating doctors to request for an early anaesthetic consultation. Postoperative pulmonary complications: why does it occur? Severe factors can individually or in combination precipitate respiratory failure should the patient fail to increase and sustain the necessary minute ventilation.

Filled symbols are affected persons. They have a mutation in the so-called TRPV4 gene. Symbols with plus sign represent

unaffected carriers of the same mutation. Symbols with minus sign are persons without this mutation. As only three out of the six persons with the mutation are affected, penetrance in this pedigree is 50% (redrawn and slightly modified from Selleckchem RAD001 Berciano et al. 2011) Another reason why it may be difficult to deduce the pattern of inheritance directly from its occurrence in a family is the phenomenon of variable expressivity. By this we mean that a given genotype may lead to different clinical pictures in different persons. One may then assume that there are several different disorders in the family, while in fact the disorders in the family members have the same underlying genetic cause. Figure 4 shows a recently reported example of variable expressivity. Fig. 4 Pedigree of a family with different manifestations of the presence of a mutation in the

FGFR1 gene (symbols with plus sign) in three family members (redrawn and slightly modified from Au et al. 2011) When two parents are carriers of an autosomal recessive disease, each child has a 25% chance of Quisinostat developing that particular disease, but this also means a 75% chance of not developing the disease. If the parents have two children, there is a 56% chance that none A-1155463 molecular weight of them has the disease. With three children there is still a 42% chance that all will be free of the disease and so on. The chance that at least two children will

be affected, thereby indicating the familial nature of the disease, is only 6% in a two-child family, 16% in a three-child family, 26% in a four-child family and so on. With smaller family sizes, the probability that an autosomal recessive disorder within a family is recognized as familial is therefore rather limited. To a lesser extent, the same restriction applies to a patient who is the first one with an autosomal dominant disorder in the family, when this person has only one child or just a few children. There are several possible reasons why a person with an autosomal dominant disease may be Vasopressin Receptor the first to show this disease in the family. The disorder may be due to a new mutation, but it may also be that one of the parents already carries the mutation, either in all his or her cells, or as a mosaic. The reason for not showing the disease if a parent carries the mutation in all cells can be a matter of incomplete penetrance or due to variable expressivity. In some disorders, whether or not a mutation is expressed, can depend on the sex of the parent who transmitted the mutation (so-called imprinting). There are also dominant and other diseases in which penetrance and expression increase from generation to generation (so-called anticipation). In this case a seemingly harmless mutation (called a premutation) develops into a full mutation by passage to the following generation.

10, the hydrophobin triple BTSA1 chemical structure mutant Δbhp3/bhp1/bhp2, and the Δbhl1 mutant (lanes with cDNA from Δbhl1 labelled with stars). M: Size markers, with relevant sizes indicated [bp]; W: Water control; G: Genomic DNA; Co: Resting conidia; My: mycelium (15 h.p.i.); To: Infected tomato leaves (48 h.p.i.); Sc: Sclerotia;

Fr: Fruiting bodies. An EF1α encoding fragment was amplified as positive control. Arrows indicate positions of bands based on cDNA (in case of ef1α, the size of cDNA and genomic DNA is identical). Undiluted first-strand cDNA was amplified with 35 cycles, except for ef1α cDNA, which was amplified from 1:10 diluted first-strand cDNA. The multiple bands obtained with BC1G_04521-specific primers Napabucasin cost might be due to different splicing variants. The weak bands indicating the presence of wild type bhp3 genomic DNA in the triple hydrophobin mutant seem to result from the presence of few remaining, non-transformed nuclei. B: Results of real-time RT-PCR, showing gene expression in conidia and selected growth stages of strain B05.10, except for fruiting bodies which were from a cross of B. cinerea field isolates. Hydrophobin expression levels are shown relative to the mean of actin and ef1α expression. Targeted deletion of bhp1, bhp2, bhp3 and bhl1 To analyse their functions, the hydrophobin genes bhp1, bhp2 and bhp3 were consecutively

deleted. Hydrophobin single knock-out mutants were constructed by using hygromycin or nourseothricin cassettes for selection. For double knock-out mutants, both cassettes were sequentially used. Finally, for generating a triple knock-out Sorafenib solubility dmso mutant, a Δbhp3/bhp1 double mutant was transformed with a bhp2 knock-out VX-770 nmr construct carrying a phleomycin resistance cassette as a third selectable marker. Additionally, a knock-out mutant of the hydrophobin-like gene bhl1 was created. All transformants were verified by PCR analysis (data not shown), and by RT-PCR using cDNA from different developmental stages (Figure 2A). No transcripts of bhp1, bhp2 and bhp3 could be detected in the hydrophobin triple mutant in any of the growth stages tested. In the same way, no transcripts of genes that had

been deleted could be amplified from hydrophobin double knock-out strains (additional file 3 : Figure S2). The expression levels of the five hydrophobin-like genes BC1G_02483, BC1G_03277, BC1G_11117, BC1G_12747 and BC1G_04521 in the hydrophobin triple mutant appeared to be similar to the wild type, as far as this could be estimated from semi-quantitative RT-PCR. Because transcripts of bhl1 could be unambiguously detected only in fruiting bodies (Figure 2A), which were unavailable from Δbhl1 mutants, verification of the Δbhl1 strain by RT-PCR analysis was not possible. Growth, differentiation and infection behaviour of the hydrophobin mutants The germination rates of hydrophobin knock-out mutants and the wild type strain were analysed under different conditions.

It might be possible that the microbiota in animals undergoing a course of antibiotic treatment is less stable and, therefore, at an increased risk for gastrointestinal disease or infections. Follow up studies over a period of years would be needed to answer this question. In this study we have evaluated healthy dogs, and it is possible that tylosin has a different effect on the microbiota in dogs with signs of gastrointestinal disease. It is suspected that diseased dogs have an altered microbial composition, and it is possible that tylosin results in modulations in microbiota that differ from those observed in the here evaluated healthy animals. Evaluating endoscopically obtained pre- and post treatment

samples from dogs with tylosin-responsive diarrhea would be valuable. Future studies ALK inhibitor will need also to evaluate intestinal

contents for changes in Wortmannin in vivo bacterial metabolites or gene expression in response to antibiotic treatment as a measure of functional redundancy of the intestinal microbiota. Studies in humans have shown that the fecal microbiota are generally resilient to short-term modulations by antibiotics, but pervasive effects might last for several months for specific bacterial taxa [8, 16]. The resilience of a microbial community reflects its capability to return to baseline after disturbances to the community (i.e., antibiotic treatment) have ceased. Less is known about the resilience of the small intestinal microbiota. find more Our results illustrate the complexity of the intestinal microbiota and the challenges associated with evaluating the effect of antibiotic administration Tyrosine-protein kinase BLK on the various bacterial groups and their potential

interactions. Our results indicate that tylosin may lead to prolonged effects on the composition and diversity of jejunal microbiota. On day 28, the phylogenetic composition of the microbiota was similar to day 0 in only 2 of 5 dogs. Bacterial diversity as measured by the Shannon-Weaver diversity index resembled the pre-treatment state in 3 of 5 dogs. Several bacterial groups changed in their proportions in response to tylosin. After cessation of tylosin, the phyla Firmicutes and Fusobacteria tended to return to pretreatment values within 14 days. Other phyla, such as Bacteroidetes, Proteobacteria, and Spirochaetes did not return to their pre-treatment proportions. Tylosin had also a pervasive effect on several bacterial groups that failed to recover by day 28 (i.e., 14 days after tylosin therapy had been completed). Those groups included Spirochaetes, Streptomycetaceae, Sphingomonadaceae, and Prevotellaceae. Tylosin has a known activity against Spirochaetes [37]. Spirochaetes have been associated with intestinal disease in chickens and pigs, but their pathogenic role in dogs remains unclear, as they are commonly observed in healthy dogs as well as dogs with diarrhea [2, 24, 38].

From then on, several articles about HFE mutations and HCC have been published. Acadesine We selected nine eligible studies including 1102 cases and 3766 controls to conduct an updated meta-analysis. Because HH is more frequent in northern European populations, the studies on HFE gene mutations and HCC are mainly come from European ethnicities. In this meta-analysis, eight studies were come from Europe and one from Africa. So, the analysis results may be mainly applicable to European populations and it warrants to be studied in other ethnicities. In this meta-analysis, the frequency of C282Y YY homozygotes was 0.42%

(16/3766), and the frequency of CY heterozygotes was 9.32% (351/3766) in all control subjects. The genotype distribution was consistent with the dbSNP data. H63D genotype distribution was 2.66% (60/2258) and 23.78% (537/2258) for DD homozygotes and HD heterozygotes in controls, respectively. As to C282Y, the ORs of allele contrast (Y vs. C) in the six studies [8,

10–12, 15, 31] were larger than 1.0. Among the six studies, four studies [8, 10–12] reported a significant association between HCC and the C282Y polymorphism (ORs > 1.0, 95%CIs did not include 1.0). Because the frequency of the homozygous mutation of C282Y is very low, and a large proportion of C282Y homozygotes had been diagnosed with HH and received treatment, such as venesection before developing LC or HCC, the conclusion SNS-032 that Roflumilast YY homozygotes increased HCC risk may have little clinical value. Thus, we only explored the dominant model and allele contrast in this meta-analysis. This meta-analysis proved that C282Y mutation was associated with HCC in European populations, especially in alcoholic LC Talazoparib nmr patients but not in viral LC patients. This result is consistent

with the results of three previous studies [8, 15, 38], and it may implicate that the hepatocarcinogenesis of alcoholic LC and viral LC is different and warrants further study. Some studies explored the role of gender in the influence of the relationship between HFE gene and HCC [10, 14, 34] and found that C282Y homozygotes YY mutation increased the risk of HCC in male patients. One English study [10] reported that male C282Y homozygotes were more likely to be diagnosed with HCC (OR = 14, 95%CI: 5-37), and the penetrance of the C282Y homozygous genotype, with respect to HCC, was between 1.31% and 2.1% for males and zero for females. Another study [36] reported that C282Y homozygote males had a relative risk (RR) of about 23 for HCC occurrence, and the penetrance, with respect to HCC, was 5.56%. As there were few studies that provided concrete gender subgroup genotype values, we could not make a pooled analysis. From the pooled genotype data, we could assess the statistical power under various subgroup analyses using PS software [27].

The strategy differs from NOGG in that FRAX is always used with BMD. Indeed, a BMD test is a prerequisite. Additionally, a fixed intervention threshold is used at all ages, whereas the NOGG strategy uses an age-dependent threshold. The rationale for a fixed threshold is based on the fracture probability at which intervention becomes cost-effective in the USA and the 20% threshold is, therefore, not relevant for any other country. Other DNA Damage inhibitor assessment models As well as the FRAX tool, other fracture risk calculators are available online which include the Garvan fracture MK-4827 supplier risk calculator and QFracture™ [69, 70]. Their comparative features are summarised in Table 9. The QFracture™ tool is based on

a UK prospective open cohort

study of routinely collected data from 357 general practices on over 2 million men and women aged 30–85 years (www.​qfracture.​org). Like the FRAX tool, it takes into account history of smoking, alcohol, corticosteroid use, parental history (of hip fracture or osteoporosis) and several secondary causes of osteoporosis. Unlike FRAX, it also includes a history of falls (yes/no only over an unspecified time frame) and excludes previous fracture history and BMD. It has been internally validated (i.e. from a stratum of the same population) and also externally validated in the UK [126]. Table 9 Comparative features of three fracture risk assessment algorithms   Dubbo/Garvan see more Qfracture FRAX Externally validated Yes (a few countries) Yes (UK only) Yes Calibrated No Yes (UK only) Yes Applicability Unknown UK 45 countries Falls as an input variable Yesa Yes No BMD as an input variable Yes No Yes Prior fracture as an input variable Yesa No Yes Family history as an input variable No Yes Yes Output Incidence Incidence Probability Treatment responses assessed No No Yes aAnd number of falls/prior fractures The Garvan tool (www.​garvan.​org.​au) is based on data from participants enrolled in the Australian Dubbo Osteoporosis epidemiology study of approximately

2,500 men and Venetoclax clinical trial women age 60 years or more. It differs from FRAX by including a history of falls (categorised as 0, 1, 2 and >2 in the previous year) and the number of previous fragility fractures (categorised as 0, 1, 2 and >2), but does not include other FRAX variables. The output of the tool differs from FRAX in that it reports the risk of a larger number of fracture sites (additionally includes fractures of the distal femur, proximal tibia/fibula, distal tibia/fibula, patella, pelvis, ribs sternum, hands and feet excluding digits). As in the case of the QFracture, the Garvan tool captures fall risk. A fundamental difference between these risk models and FRAX is that the parameters of risk differ (incidence vs. probabilities) so that comparative data are not readily interpreted [127] (Fig. 10).

Uslu F, Ingebrandt S, Mayer D, Böcker-Meffert S, Odenthal M, Offenhäusser A: Labelfree fully electronic nucleic acid detection system based on a field-effect transistor

device. Biosens Bioelectron 2004,19(12):1723–1731.CrossRef 19. Berney H, West J, Haefele E, Alderman LY333531 mouse J, Lane W, Collins J: A DNA diagnostic biosensor: development, selleck chemicals llc characterisation and performance. Sensors and Actuators B: Chem 2000, 68:100–108.CrossRef 20. Pouthas F, Gentil C, Côte D, Bockelmann U: DNA detection on transistor arrays following mutation-specific enzymatic amplification. Appl Phys Lett 2004,84(9):1594–1596.CrossRef 21. Sassolas A, Leca-Bouvier BD, Blum LJ: DNA biosensors and microarrays. Chem Rev 2008, 108:109–139.CrossRef 22. Drummond T, Hill M, Barton J: Electrochemical DNA sensors.

Nat Biotechnol 2003,21(10):1192–1199.CrossRef 23. Schwierz F: APR-246 nmr Graphene transistors. Nat Nanotechnol 2010,5(7):487–496.CrossRef 24. Geim AK, MacDonald AH: Graphene: exploring carbon flatland. Phys Today 2007, 60:35.CrossRef 25. Geim AK, Novoselov KS: The rise of graphene. Nat Mater 2007,6(3):183–191.CrossRef 26. Gurung P, Deo N: Electronic transport in DNA functionalized graphene sensors. arXiv preprint arXiv:1309.3373 2013. 27. Wang W, He S: Theoretical analysis on response mechanism of polymer-coated chemical sensor based Love wave in viscoelastic media. Sensors and Actuators B: Chem 2009,138(2):432–440. [http://​www.​sciencedirect.​com/​science/​article/​pii/​S092540050900203​2]CrossRef 28. Dong X, Shi Y, Huang W, Chen P, Li LJ: Electrical detection of DNA hybridization with single-base specificity Isoconazole using transistors based on CVD-grown graphene sheets. Adv Mater 2010,22(14):1649-+.CrossRef 29. Poghossian A, Cherstvy A, Ingebrandt S, Offenhausser A, Schoning M: Possibilities and limitations of label-free detection of DNA hybridization with

field-effect-based devices. Sensors and Actuators B: Chemical 2005, 111:470–480.CrossRef 30. Tel-Vered R, Willner B, Willner I: Biohybrid Electrochemical Devices. Hoboken: Wiley; 2010. [http://​dx.​doi.​org/​10.​1002/​9780470583463.​ch12] 31. Ahmadi M, Johari Z, Amin N, Fallahpour A, Ismail R: Graphene nanoribbon conductance model in parabolic band structure. J Nanomater 2010, 2010:12.CrossRef 32. Abadi HKF, Yusof R, Eshrati SM, Naghib S, Rahmani M, Ghadiri M, Akbari E, Ahmadi M: Current-voltage modeling of graphene-based DNA sensor. Neural Comput Appl 2013, 24:1–5. 33. Huang B, Tai N, Huang W: Optimization and coordination of HAFDV PINN control by improved PSO. J Control Sci Eng 2013, 2013:7. 34. He W, Cheng Y, Xia L, Liu F: A new particle swarm optimization-based method for phase unwrapping of MRI data. Comput Math Methods Med 2012, 2012:9. 35. Rahmani R, Khairuddin A, Cherati SM, Pesaran HAM: A novel method for optimal placing wind turbines in a wind farm using particle swarm optimization (PSO). In 2010 Conference Proceedings (IPEC): 27–29 Oct 2010; Singapore. Piscataway: IEEE; 2010:134–139.CrossRef 36.

Why and how to bridge the gaps When it comes to evaluating the Momelotinib success of

field actions, ecosystem protection and biodiversity conservation lags behind many other policy fields (e.g. poverty reduction, minimal rehabilitation, disease control) (cf. Millennium Ecosystem Assessment, MEA 2005a, b). However, if we want to ensure that the limited (financial) resources devoted to conservation make a practical difference, we should test conservation policies with equal thoroughness and state-of-the-art methods as we do in conservation science. Hereby, approaches check details from various fields of science could help to improve the efficiency in conservation actions. Therefore, bridging the gaps between both fields would be synergistic. Based on the results from the questionnaires we make the

following suggestions to bridge the three gaps identified above. Stimulate mutual interaction and translation (overcoming the knowing-doing gap) There is a wealth of literature on expert elicitation, decision theory, and risk analysis—all of which can be important Selleck Quisinostat aspects of conservation—but technical terminology can be especially impenetrable to practitioners. In turn, field practitioners should document their field experiences and experiments in a manner that can meaningfully inform conservation scientists. To address this point, we asked all contributors to this special issue on European grasslands to (1) translate

their key-findings on short-term activities for conservation practitioners, (2) to separate long-term effects from short-term activities, and (3) to evaluate how the impact of the respective action (conservation efficiency) could be translated into the conservation practitioner’s language (see Table 1 in Appendix). Erastin Several authors commented in their questionnaire that a “Conservation Management Abstract”, a summary in which theoretical findings are being translated in specific conservation management advice, would be an important step in overcoming the “knowing-doing” gap. We therefore suggest that journals publishing studies relevant for the field of conservation should consider requiring a practical abstract that has to be open-access and published at the beginning of each article (e.g. just after the conventional abstract).